{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:02:47Z","timestamp":1792512167809,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.drugalcdep.2020.108297","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T11:38:25Z","timestamp":1600169905000},"page":"108297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty \u2014 United States, 2014\u20132019"],"prefix":"10.1016","volume":"217","author":[{"given":"Amy R.","family":"Board","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gery","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Hoots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108297_bib0005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2165\/11584590-000000000-00000","article-title":"Medication costs to private insurers of diversion of medications for attention-deficit hyperactivity disorder","volume":"29","author":"Aldridge","year":"2011","journal-title":"PharmacoEcon."},{"key":"10.1016\/j.drugalcdep.2020.108297_bib0010","unstructured":"American Psychiatric Association, 2013. Attention deficit\/hyperactivity disorder. https:\/\/www.psychiatry.org\/psychiatrists\/practice\/dsm\/educational-resources\/dsm-5-fact-sheets. (Accessed September 2, 2020)."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108297_bib0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.15585\/mmwr.mm6702a3","article-title":"Attention-deficit\/hyperactivity disorder medication prescription claims among privately insured women aged 15-44 years - United States, 2003-2015","volume":"67","author":"Anderson","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108297_bib0020","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1176\/appi.ajp.2018.18050596","article-title":"Prescription stimulant use and misuse: implications for responsible prescribing practices","volume":"175","author":"Arria","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108297_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10567-014-0177-z","article-title":"Misuse of stimulant medication among college students: a comprehensive review and meta-analysis","volume":"18","author":"Benson","year":"2015","journal-title":"Clin. Child Fam. Psychol. Rev."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108297_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/mp.2008.90","article-title":"Potential adverse effects of amphetamine treatment on brain and behavior: a review","volume":"14","author":"Berman","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108297_bib0035","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamapsychiatry.2016.1182","article-title":"Trends in stimulant medication use in commercially insured youths and adults, 2010-2014","volume":"73","author":"Burcu","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108297_bib0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5694\/mja15.00791","article-title":"ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004-2014","volume":"204","author":"Cairns","year":"2016","journal-title":"Med. J. Aust."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108297_bib0045","first-page":"23","article-title":"Seasonality and the changing adult\/child prescription ratios in ADHD therapy","volume":"5","author":"Cascade","year":"2008","journal-title":"Psychiatry (Edgmont)"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108297_bib0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3810\/pgm.2014.09.2801","article-title":"The potential for misuse and abuse of medications in ADHD: a review","volume":"126","author":"Clemow","year":"2014","journal-title":"Postgrad. Med."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108297_bib0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.2018.17091048","article-title":"Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States","volume":"175","author":"Compton","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.108297_bib0060","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/s41386-018-0207-5","article-title":"Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit\/hyperactivity disorder","volume":"43","author":"Curtin","year":"2018","journal-title":"Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108297_bib0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/15374416.2017.1417860","article-title":"Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016","volume":"47","author":"Danielson","year":"2018","journal-title":"J. Clin. Child Adolesc. Psychol."},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108297_bib0070","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/jpepsy\/jsv105","article-title":"Diversion of ADHD stimulants and victimization among adolescents","volume":"41","author":"Epstein-Ngo","year":"2016","journal-title":"J. Pediatr. Psychol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108297_bib0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaac.2019.06.012","article-title":"Systematic review: nonmedical use of prescription stimulants: risk factors, outcomes, and risk reduction strategies","volume":"59","author":"Faraone","year":"2019","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.108297_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40360-015-0035-8","article-title":"Use of prescription stimulant for attention deficit hyperactivity disorder in aboriginal children and adolescents: a linked data cohort study","volume":"16","author":"Ghosh","year":"2015","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108297_bib0085","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.4088\/JCP.17m11760","article-title":"National trends in and correlates of nonmedical use of prescription stimulants, nonmedical use frequency, and use disorders","volume":"78","author":"Han","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108297_bib0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.15585\/mmwr.mm6912a1","article-title":"Patterns and characteristics of methamphetamine use among adults - United States, 2015-2018","volume":"69","author":"Jones","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108297_bib0095","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication","volume":"163","author":"Kessler","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108297_bib0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat. Med."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108297_bib0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/YCO.0000000000000172","article-title":"Diversion of prescription stimulant drugs among 10-18-year-olds","volume":"28","author":"Lasopa","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108297_bib0110","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1186\/s12889-018-6212-0","article-title":"Non-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use","volume":"18","author":"Lucke","year":"2018","journal-title":"BMC Public Health"},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108297_bib0115","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.addbeh.2014.03.008","article-title":"Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: connecting the dots","volume":"39","author":"McCabe","year":"2014","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108297_bib0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jaac.2016.12.008","article-title":"Adolescents\u2019 prescription stimulant use and adult functional outcomes: a national prospective study","volume":"56","author":"McCabe","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108297_bib0125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/bcp.13544","article-title":"Patterns and profiles of methylphenidate use both in children and adults","volume":"84","author":"Pauly","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108297_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206100","article-title":"Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016","volume":"13","author":"Piper","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108297_bib0135","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/bcp.13000","article-title":"Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015","volume":"82","author":"Renoux","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108297_bib0140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1087054715605915","article-title":"Recent trends in stimulant usage","volume":"20","author":"Safer","year":"2016","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.drugalcdep.2020.108297_bib0145","unstructured":"Substance Abuse and Mental Health Services Administration, 2019. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health. Rockville, MD. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHNationalFindingsReport2018\/NSDUHNationalFindingsReport2018.pdf. (Accessed April 4, 2020)."},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108297_bib0150","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1592\/phco.26.10.1501","article-title":"Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration","volume":"26","author":"Teter","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drugalcdep.2020.108297_bib0155","article-title":"Age- and sex-specific increases in stimulant prescribing rates-California, 2008-2017","author":"Tseregounis","year":"2019","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.drugalcdep.2020.108297_bib0160","series-title":"U.S. Census Bureau","author":"U.S. Census Bureau","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108297_bib0165","series-title":"Controlled Substance Schedules","author":"U.S. Department of Justice Drug Enforcement Administration","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108297_bib0170","series-title":"Adderall","author":"U.S. National Library of Medicine","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108297_bib0175","series-title":"Amphetamine Sulfate","author":"U.S. National Library of Medicine","year":"2020"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108297_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2013.09.001","article-title":"Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit\/hyperactivity disorder: United States, 2003\u20132011","volume":"53","author":"Visser","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108297_bib0185","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1017\/S0033291716002853","article-title":"Exploring DSM-5 ADHD criteria beyond young adulthood: phenomenology, psychometric properties and prevalence in a large three-decade birth cohort","volume":"47","author":"Vitola","year":"2017","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108297_bib0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2011.11030387","article-title":"Stimulant medication use in children: a 12-year perspective","volume":"169","author":"Zuvekas","year":"2012","journal-title":"Am. J. Psychiatry"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:08:33Z","timestamp":1759828113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620304622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":38,"alternative-id":["S0376871620304622"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108297","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty \u2014 United States, 2014\u20132019","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108297"}}